Now showing items 1-9 of 9

  • Konijnenberg, Elles; Tijms, Betty M; Gobom, Johan; Dobricic, Valerija; Bos, Isabelle; Vos, Stephanie; Tsolaki, Magda; Verhey, Frans; Popp, Julius; Martinez-Lage, Pablo; Vandenberghe, Rik; Lleó, Alberto; Frölich, Lutz; Lovestone, Simon; Streffer, Johannes; Bertram, Lars; Blennow, Kaj; Teunissen, Charlotte E; Veerhuis, Robert; Smit, August B; Scheltens, Philip; Zetterberg, Henrik; Visser, Pieter J (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2020)
    Background Aggregation of amyloid β into plaques in the brain is one of the earliest pathological events in Alzheimer’s disease (AD). The exact pathophysiology leading to dementia is still uncertain, but the apolipoprotein ...
  • Visser, Pieter J.; Reus, Lianne M.; Gobom, Johan; Jansen, Iris; Dicks, Ellen; van der Lee, Sven J.; Tsolaki, Magda; Verhey, Frans R. J.; Popp, Julius; Martinez-Lage, Pablo; Vandenberghe, Rik; Lleó, Alberto; Molinuevo, José L.; Engelborghs, Sebastiaan; Freund-Levi, Yvonne; Froelich, Lutz; Sleegers, Kristel; Dobricic, Valerija; Lovestone, Simon; Streffer, Johannes; Vos, Stephanie J. B.; Bos, Isabelle; Smit, August B.; Blennow, Kaj; Scheltens, Philip; Teunissen, Charlotte E.; Bertram, Lars; Zetterberg, Henrik; Tijms, Betty M. (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2022)
    Background Increased total tau (t-tau) in cerebrospinal fluid (CSF) is a key characteristic of Alzheimer’s disease (AD) and is considered to result from neurodegeneration. T-tau levels, however, can be ...
  • Henjum, Kristi; Quist-Paulsen, Else; Zetterberg, Henrik; Blennow, Kaj; Nilsson, Lars N G; Watne, Leiv O (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2018)
    Background Delirium and dementia share symptoms of cognitive dysfunctions, and mechanisms of neuroinflammation appear involved in both conditions. Triggering receptor expressed on myeloid cells 2 (TREM2) ...
  • Selnes, Per; Blennow, Kaj; Zetterberg, Henrik; Grambaite, Ramune; Rosengren, Lars; Johnsen, Lisbeth; Stenset, Vidar; Fladby, Tormod (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2010)
    Background Alzheimer's disease (AD) and cerebrovascular disease (CVD) including chronic small vessel disease of the brain (SVD) are the most frequent causes of dementia. AD is associated with metabolism ...
  • Desikan, Rahul S; Thompson, Wesley K; Holland, Dominic; Hess, Christopher P; Brewer, James B; Zetterberg, Henrik; Blennow, Kaj; Andreassen, Ole A; McEvoy, Linda K; Hyman, Bradley T; Dale, Anders M (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2013)
    Background Epidemiological and molecular findings suggest a relationship between Alzheimer’s disease (AD) and dyslipidemia, although the nature of this association is not well understood. ...
  • ten Kate, Mara; Redolfi, Alberto; Peira, Enrico; Bos, Isabelle; Vos, Stephanie J; Vandenberghe, Rik; Gabel, Silvy; Schaeverbeke, Jolien; Scheltens, Philip; Blin, Olivier; Richardson, Jill C; Bordet, Regis; Wallin, Anders; Eckerstrom, Carl; Molinuevo, José L; Engelborghs, Sebastiaan; Van Broeckhoven, Christine; Martinez-Lage, Pablo; Popp, Julius; Tsolaki, Magdalini; Verhey, Frans R J; Baird, Alison L; Legido-Quigley, Cristina; Bertram, Lars; Dobricic, Valerija; Zetterberg, Henrik; Lovestone, Simon; Streffer, Johannes; Bianchetti, Silvia; Novak, Gerald P; Revillard, Jerome; Gordon, Mark F; Xie, Zhiyong; Wottschel, Viktor; Frisoni, Giovanni; Visser, Pieter J; Barkhof, Frederik (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2018)
    Background With the shift of research focus towards the pre-dementia stage of Alzheimer’s disease (AD), there is an urgent need for reliable, non-invasive biomarkers to predict amyloid pathology. The aim ...
  • Neumann, Alexander; Ohlei, Olena; Küçükali, Fahri; Bos, Isabelle J.; Timsina, Jigyasha; Vos, Stephanie; Prokopenko, Dmitry; Tijms, Betty M.; Andreasson, Ulf; Blennow, Kaj; Vandenberghe, Rik; Scheltens, Philip; Teunissen, Charlotte E.; Engelborghs, Sebastiaan; Frisoni, Giovanni B.; Blin, Oliver; Richardson, Jill C.; Bordet, Régis; Lleó, Alberto; Alcolea, Daniel; Popp, Julius; Marsh, Thomas W.; Gorijala, Priyanka; Clark, Christopher; Peyratout, Gwendoline; Martinez-Lage, Pablo; Tainta, Mikel; Dobson, Richard J. B.; Legido-Quigley, Cristina; Van Broeckhoven, Christine; Tanzi, Rudolph E.; ten Kate, Mara; Lill, Christina M.; Barkhof, Frederik; Cruchaga, Carlos; Lovestone, Simon; Streffer, Johannes; Zetterberg, Henrik; Visser, Pieter J.; Sleegers, Kristel; Bertram, Lars (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2023)
    Background Genome-wide association studies (GWAS) of Alzheimer’s disease (AD) have identified several risk loci, but many remain unknown. Cerebrospinal fluid (CSF) biomarkers may aid in gene discovery and ...
  • Stockfelt, Marit; Lundell, Anna-Carin; Hetland, Merete L.; Østergaard, Mikkel; Uhlig, Till; Heiberg, Marte S.; Haavardsholm, Espen A.; Nurmohamed, Michael T.; Lampa, Jon; Nordström, Dan; Petersen, Kim H.; Gudbjornsson, Bjorn; Gröndal, Gerdur; Aldridge, Jonathan; Andersson, Kerstin; Blennow, Kaj; Zetterberg, Henrik; van Vollenhoven, Ronald; Rudin, Anna (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2021)
    Background The type I interferon (IFN) gene signature is present in a subgroup of patients with early rheumatoid arthritis (RA). Protein levels of IFNα have not been measured in RA and it is unknown whether ...
  • Bos, Isabelle; Vos, Stephanie; Vandenberghe, Rik; Scheltens, Philip; Engelborghs, Sebastiaan; Frisoni, Giovanni; Molinuevo, José L; Wallin, Anders; Lleó, Alberto; Popp, Julius; Martinez-Lage, Pablo; Baird, Alison; Dobson, Richard; Legido-Quigley, Cristina; Sleegers, Kristel; Van Broeckhoven, Christine; Bertram, Lars; ten Kate, Mara; Barkhof, Frederik; Zetterberg, Henrik; Lovestone, Simon; Streffer, Johannes; Visser, Pieter J (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2018)
    Background There is an urgent need for novel, noninvasive biomarkers to diagnose Alzheimer’s disease (AD) in the predementia stages and to predict the rate of decline. Therefore, we set up the European ...